Allison L Naleway
Overview
Explore the profile of Allison L Naleway including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
4718
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cox S, Roychoudhury P, Frivold C, Acker Z, Babu T, Boisvert C, et al.
Clin Infect Dis
. 2025 Mar;
PMID: 40084542
Background: Household transmission of respiratory viruses may drive community spread. Few recent studies have examined household respiratory syncytial virus (RSV) transmission in the United States. Methods: We conducted a prospective...
2.
Link-Gelles R, Chickery S, Webber A, Ong T, Rowley E, DeSilva M, et al.
MMWR Morb Mortal Wkly Rep
. 2025 Feb;
74(6):73-82.
PMID: 40014628
COVID-19 vaccination averted approximately 68,000 hospitalizations during the 2023-24 respiratory season. In June 2024, CDC and the Advisory Committee on Immunization Practices (ACIP) recommended that all persons aged ≥6 months...
3.
Kuntz J, Babu T, Feldstein L, Englund J, Frivold C, Groom H, et al.
Pediatr Infect Dis J
. 2025 Feb;
44(2S):S162-S166.
PMID: 39951097
Background: Respiratory syncytial virus (RSV) is the leading cause of hospitalization among infants in the United States (US). RSV immunization, in the form of a monoclonal antibody (mAb) for infants...
4.
Naleway A, Crane B, Irving S, Daley M, Dixon B, Donahue J, et al.
Pediatr Infect Dis J
. 2025 Feb;
44(2S):S105-S107.
PMID: 39951085
We described vaccinations during pregnancies starting in 2002 through 2022 in 8 Vaccine Safety Datalink healthcare organizations in the United States. During this period, the number of vaccinations per pregnancy...
5.
Rowley E, Mitchell P, Yang D, Lewis N, Dixon B, Vazquez-Benitez G, et al.
JMIR Form Res
. 2025 Jan;
9:e58981.
PMID: 39869907
Background: Real-world COVID-19 vaccine effectiveness (VE) studies are investigating exposures of increasing complexity accounting for time since vaccination. These studies require methods that adjust for the confounding that arises when...
6.
Feldstein L, Ruffin J, Wiegand R, Borkowf C, James-Gist J, Babu T, et al.
J Infect Dis
. 2025 Jan;
PMID: 39774936
Background: Understanding protection against SARS-CoV-2 infection by vaccine and hybrid immunity is important for informing public health strategies as new variants emerge. Methods: We analyzed data from three cohort studies...
7.
Hollister J, Porter C, Sprissler R, Beitel S, Romine J, Uhrlaub J, et al.
PLoS One
. 2024 Dec;
19(12):e0306953.
PMID: 39739951
The extent to which semi-quantitative antibody levels confer protection against SARS-CoV-2 infection in populations with heterogenous immune histories is unclear. Two nested case-control studies were designed within the multisite HEROES/RECOVER...
8.
Park J, Bartzoka F, von Beck T, Li Z, Mishina M, Hebert L, et al.
Lancet Microbe
. 2024 Dec;
6(2):100935.
PMID: 39667375
Background: Egg-based inactivated quadrivalent seasonal influenza vaccine (eIIV4), cell culture-based inactivated quadrivalent seasonal influenza vaccine (ccIIV4), and recombinant haemagglutinin (HA)-based quadrivalent seasonal influenza vaccine (RIV4) have been licensed for use...
9.
Feldstein L, Ruffin J, Wiegand R, Grant L, Babu T, Briggs-Hagen M, et al.
J Pediatric Infect Dis Soc
. 2024 Dec;
14(1.
PMID: 39656907
To understand how coronavirus disease 2019 vaccines impact infection risk in children <5 years, we assessed risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from September 2022 to...
10.
Tenforde M, Reeves E, Weber Z, Tartof S, Klein N, Dascomb K, et al.
Clin Infect Dis
. 2024 Dec;
PMID: 39656838
Background: The 2023-2024 influenza season had predominant influenza A(H1N1)pdm09 virus activity, but A(H3N2) and B viruses co-circulated. Seasonal influenza vaccine strains were well-matched to these viruses. Methods: Using health care...